Share Price and Basic Stock Data
Last Updated: January 7, 2026, 7:16 pm
| PEG Ratio | -10.20 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Relaxo Footwears Ltd, a prominent player in the Indian footwear industry, reported a market capitalization of ₹10,067 Cr and a stock price of ₹404. The company has shown a consistent upward trajectory in sales, with the latest figures indicating revenues of ₹2,783 Cr for FY 2023 and ₹2,914 Cr projected for FY 2024. In the recent quarterly performance, sales for September 2023 stood at ₹715 Cr, slightly declining from ₹739 Cr in June 2023. However, the company has managed to maintain a stable sales range, with the highest quarterly sales recorded at ₹765 Cr in March 2023. Notably, Relaxo’s operational efficiency is reflected in its ability to sustain sales growth despite fluctuations in market conditions, showcasing resilience against sector challenges. The reported sales growth from ₹2,410 Cr in FY 2020 to ₹2,783 Cr in FY 2023 demonstrates a robust compound annual growth rate (CAGR), indicating a solid demand for its products in the competitive footwear market.
Profitability and Efficiency Metrics
Relaxo Footwears Ltd reported a net profit of ₹174 Cr for the trailing twelve months, with a profit margin of approximately 6.10%. The operating profit margin (OPM) stood at 13% for FY 2023, reflecting a decline from 16% in FY 2024, indicating pressure on margins possibly due to rising input costs or competitive pricing strategies. The company’s return on equity (ROE) was recorded at 8.31%, while the return on capital employed (ROCE) stood at 11.2%, both of which are relatively low compared to industry standards. Additionally, the interest coverage ratio (ICR) of 19.79x signifies that Relaxo maintains a strong capability to meet its interest obligations, which is a positive indicator of financial health. However, the cash conversion cycle (CCC) of 155 days could be a concern, as it suggests a longer time frame for converting inventory into cash, potentially impacting liquidity. Overall, while Relaxo’s profitability metrics indicate stable performance, the pressure on margins and efficiency ratios warrants close monitoring.
Balance Sheet Strength and Financial Ratios
Relaxo Footwears Ltd’s balance sheet reflects a strong position, with total assets valued at ₹2,762 Cr and reserves amounting to ₹2,085 Cr. The company’s borrowings stood at ₹215 Cr, indicating a low debt-to-equity ratio of 0.00, which underscores its financial prudence and minimal reliance on debt financing. The current ratio of 2.74x indicates robust liquidity, suggesting that Relaxo can comfortably cover its short-term liabilities. Additionally, the price-to-book value (P/BV) ratio of 4.83x suggests that the market values the company significantly higher than its book value, reflecting investor confidence. However, the inventory turnover ratio of 4.82x is relatively low, indicating that the company may be holding excess stock, which could tie up capital. The efficiency metrics, such as the cash conversion cycle and the asset turnover ratio of 1.02, highlight areas for improvement, particularly in managing working capital more effectively.
Shareholding Pattern and Investor Confidence
As of September 2025, Relaxo Footwears Ltd’s shareholding pattern shows that promoters hold a significant 71.27% stake, demonstrating strong control over the company. Foreign institutional investors (FIIs) account for 3.04%, while domestic institutional investors (DIIs) hold 9.88%, indicating moderate institutional interest. The public’s shareholding stands at 15.82%, reflecting a diversified ownership structure. The number of shareholders has decreased from 3,61,927 in December 2022 to 2,39,270, suggesting a consolidation of ownership, which may be indicative of strategic decisions by major stakeholders. The dividend payout ratio has increased to 44% for FY 2025, signaling a commitment to returning profits to shareholders, which can enhance investor confidence. However, the declining number of shareholders could raise concerns about liquidity and market participation, necessitating efforts to attract retail investors and maintain a vibrant trading environment.
Outlook, Risks, and Final Insight
Looking ahead, Relaxo Footwears Ltd’s growth prospects remain contingent on its ability to navigate challenges such as margin pressures and managing working capital effectively. The company’s strong balance sheet positions it well to invest in growth opportunities and enhance operational efficiency. However, risks include potential disruptions in supply chains and fluctuations in consumer demand, which could impact sales and profitability. Additionally, the footwear industry is highly competitive, with evolving consumer preferences and pricing pressures posing ongoing challenges. To mitigate these risks, Relaxo must focus on innovation and product differentiation while enhancing its distribution channels. Should the company successfully leverage its strengths in brand equity and operational capabilities, it could capitalize on growth opportunities in the expanding Indian footwear market. Ultimately, Relaxo’s ability to adapt to market dynamics will determine its long-term sustainability and success in a competitive landscape.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Campus Activewear Ltd | 7,884 Cr. | 258 | 315/210 | 63.7 | 26.0 | 0.39 % | 20.1 % | 17.2 % | 5.00 |
| AKI India Ltd | 64.9 Cr. | 6.32 | 16.2/6.00 | 32.8 | 8.35 | 0.00 % | 4.54 % | 1.80 % | 2.00 |
| Relaxo Footwears Ltd | 10,006 Cr. | 402 | 628/375 | 57.4 | 84.7 | 0.75 % | 11.2 % | 8.31 % | 1.00 |
| Liberty Shoes Ltd | 468 Cr. | 278 | 517/260 | 35.1 | 134 | 0.00 % | 9.99 % | 7.20 % | 10.0 |
| Khadim India Ltd | 336 Cr. | 183 | 330/153 | 23.4 | 90.2 | 0.00 % | 9.34 % | 2.20 % | 10.0 |
| Industry Average | 6,146.40 Cr | 343.89 | 46.18 | 77.04 | 0.53% | 11.71% | 8.72% | 5.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 670 | 681 | 765 | 739 | 715 | 713 | 747 | 748 | 679 | 667 | 695 | 654 | 629 |
| Expenses | 610 | 609 | 647 | 631 | 624 | 626 | 627 | 649 | 592 | 584 | 583 | 555 | 547 |
| Operating Profit | 59 | 72 | 118 | 108 | 92 | 87 | 120 | 99 | 88 | 83 | 112 | 99 | 81 |
| OPM % | 9% | 11% | 15% | 15% | 13% | 12% | 16% | 13% | 13% | 12% | 16% | 15% | 13% |
| Other Income | 6 | 4 | 4 | 7 | 11 | 6 | 5 | 5 | 7 | 7 | 8 | 11 | 12 |
| Interest | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Depreciation | 31 | 32 | 33 | 35 | 37 | 38 | 38 | 39 | 40 | 40 | 39 | 40 | 39 |
| Profit before tax | 30 | 41 | 85 | 76 | 60 | 51 | 82 | 60 | 50 | 45 | 75 | 66 | 49 |
| Tax % | 26% | 26% | 26% | 26% | 27% | 24% | 25% | 26% | 26% | 26% | 25% | 26% | 26% |
| Net Profit | 22 | 30 | 63 | 56 | 44 | 39 | 61 | 44 | 37 | 33 | 56 | 49 | 36 |
| EPS in Rs | 0.90 | 1.21 | 2.54 | 2.26 | 1.78 | 1.55 | 2.47 | 1.78 | 1.48 | 1.33 | 2.26 | 1.96 | 1.45 |
Last Updated: December 29, 2025, 9:16 am
Below is a detailed analysis of the quarterly data for Relaxo Footwears Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 629.00 Cr.. The value appears to be declining and may need further review. It has decreased from 654.00 Cr. (Jun 2025) to 629.00 Cr., marking a decrease of 25.00 Cr..
- For Expenses, as of Sep 2025, the value is 547.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 555.00 Cr. (Jun 2025) to 547.00 Cr., marking a decrease of 8.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 81.00 Cr.. The value appears to be declining and may need further review. It has decreased from 99.00 Cr. (Jun 2025) to 81.00 Cr., marking a decrease of 18.00 Cr..
- For OPM %, as of Sep 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Jun 2025) to 13.00%, marking a decrease of 2.00%.
- For Other Income, as of Sep 2025, the value is 12.00 Cr.. The value appears strong and on an upward trend. It has increased from 11.00 Cr. (Jun 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Sep 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 5.00 Cr..
- For Depreciation, as of Sep 2025, the value is 39.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 40.00 Cr. (Jun 2025) to 39.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 66.00 Cr. (Jun 2025) to 49.00 Cr., marking a decrease of 17.00 Cr..
- For Tax %, as of Sep 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 26.00%.
- For Net Profit, as of Sep 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 49.00 Cr. (Jun 2025) to 36.00 Cr., marking a decrease of 13.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 1.45. The value appears to be declining and may need further review. It has decreased from 1.96 (Jun 2025) to 1.45, marking a decrease of 0.51.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:44 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,180 | 1,441 | 1,668 | 1,631 | 1,941 | 2,292 | 2,410 | 2,359 | 2,653 | 2,783 | 2,914 | 2,790 | 2,645 |
| Expenses | 1,032 | 1,240 | 1,427 | 1,400 | 1,639 | 1,964 | 1,998 | 1,861 | 2,235 | 2,442 | 2,505 | 2,405 | 2,269 |
| Operating Profit | 148 | 201 | 241 | 231 | 302 | 328 | 413 | 498 | 418 | 341 | 409 | 385 | 376 |
| OPM % | 13% | 14% | 14% | 14% | 16% | 14% | 17% | 21% | 16% | 12% | 14% | 14% | 14% |
| Other Income | 2 | 0 | 7 | 14 | 4 | 12 | 8 | 22 | 23 | 16 | 29 | 27 | 38 |
| Interest | 23 | 18 | 23 | 15 | 9 | 9 | 19 | 19 | 17 | 22 | 21 | 24 | 21 |
| Depreciation | 31 | 40 | 47 | 51 | 54 | 62 | 109 | 110 | 114 | 125 | 147 | 158 | 159 |
| Profit before tax | 96 | 143 | 178 | 178 | 244 | 268 | 292 | 391 | 311 | 210 | 269 | 230 | 235 |
| Tax % | 31% | 28% | 32% | 33% | 34% | 35% | 22% | 25% | 25% | 26% | 26% | 26% | |
| Net Profit | 66 | 103 | 120 | 120 | 161 | 175 | 226 | 292 | 233 | 154 | 200 | 170 | 174 |
| EPS in Rs | 2.74 | 4.29 | 5.01 | 4.99 | 6.69 | 7.07 | 9.11 | 11.74 | 9.35 | 6.21 | 8.05 | 6.84 | 7.00 |
| Dividend Payout % | 5% | 6% | 6% | 10% | 11% | 13% | 14% | 21% | 27% | 40% | 37% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 56.06% | 16.50% | 0.00% | 34.17% | 8.70% | 29.14% | 29.20% | -20.21% | -33.91% | 29.87% | -15.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -39.56% | -16.50% | 34.17% | -25.47% | 20.45% | 0.06% | -49.41% | -13.70% | 63.78% | -44.87% |
Relaxo Footwears Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -6% |
| 3 Years: | -10% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -5% |
| 3 Years: | -21% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 9% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:05 pm
Balance Sheet
Last Updated: December 4, 2025, 1:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 12 | 12 | 12 | 12 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 271 | 362 | 468 | 594 | 749 | 1,093 | 1,248 | 1,548 | 1,735 | 1,830 | 1,976 | 2,073 | 2,085 |
| Borrowings | 198 | 239 | 236 | 178 | 153 | 112 | 139 | 144 | 174 | 164 | 205 | 213 | 215 |
| Other Liabilities | 182 | 234 | 281 | 286 | 335 | 394 | 430 | 459 | 448 | 476 | 508 | 452 | 545 |
| Total Liabilities | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,870 |
| Fixed Assets | 366 | 472 | 531 | 541 | 525 | 848 | 981 | 938 | 987 | 1,150 | 1,371 | 1,344 | 1,336 |
| CWIP | 24 | 2 | 28 | 62 | 138 | 11 | 46 | 118 | 149 | 89 | 33 | 54 | 75 |
| Investments | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 338 | 194 | 225 | 108 | 343 | 422 |
| Other Assets | 267 | 367 | 438 | 466 | 587 | 752 | 814 | 782 | 1,052 | 1,030 | 1,202 | 1,021 | 1,037 |
| Total Assets | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,870 |
Below is a detailed analysis of the balance sheet data for Relaxo Footwears Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,073.00 Cr. (Mar 2025) to 2,085.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 215.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 213.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 545.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 452.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 93.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,870.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,344.00 Cr. (Mar 2025) to 1,336.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 21.00 Cr..
- For Investments, as of Sep 2025, the value is 422.00 Cr.. The value appears strong and on an upward trend. It has increased from 343.00 Cr. (Mar 2025) to 422.00 Cr., marking an increase of 79.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,037.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,021.00 Cr. (Mar 2025) to 1,037.00 Cr., marking an increase of 16.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,870.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (2,085.00 Cr.) exceed the Borrowings (215.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -50.00 | -38.00 | 5.00 | 53.00 | 149.00 | 216.00 | 274.00 | 354.00 | 244.00 | 177.00 | 204.00 | 172.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 21 | 24 | 28 | 33 | 35 | 26 | 28 | 34 | 35 | 45 | 41 |
| Inventory Days | 109 | 163 | 147 | 146 | 130 | 130 | 157 | 154 | 202 | 154 | 179 | 177 |
| Days Payable | 39 | 61 | 63 | 63 | 72 | 58 | 65 | 81 | 67 | 69 | 76 | 63 |
| Cash Conversion Cycle | 91 | 123 | 108 | 110 | 90 | 107 | 119 | 101 | 170 | 121 | 148 | 155 |
| Working Capital Days | 5 | 14 | 12 | 19 | 27 | 42 | 57 | 44 | 75 | 59 | 68 | 62 |
| ROCE % | 26% | 30% | 30% | 26% | 30% | 26% | 24% | 26% | 18% | 12% | 14% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 11,800,000 | 1.33 | 482.92 | 1,800,000 | 2025-12-08 01:55:51 | 555.56% |
| SBI Large & Midcap Fund | 4,049,449 | 0.45 | 165.72 | 1,550,000 | 2025-12-08 01:55:51 | 161.25% |
| SBI Equity Hybrid Fund | 2,533,988 | 0.13 | 103.7 | 2,533,988 | 2025-04-22 15:16:47 | 0% |
| SBI Magnum Childrens Benefit Fund - Investment Plan | 1,812,156 | 1.47 | 74.16 | 400,000 | 2025-12-08 01:55:51 | 353.04% |
| SBI Multicap Fund | 1,621,704 | 0.28 | 66.37 | 1,621,704 | 2025-04-22 15:56:54 | 0% |
| SBI Flexicap Fund | 1,347,099 | 0.23 | 55.13 | N/A | N/A | N/A |
| ICICI Prudential Bharat Consumption Fund | 307,585 | 0.39 | 12.59 | N/A | N/A | N/A |
| SBI Consumption Opportunities Fund | 290,000 | 0.37 | 11.87 | N/A | N/A | N/A |
| ICICI Prudential FMCG Fund | 221,692 | 0.46 | 9.07 | N/A | N/A | N/A |
| UTI Multi Asset Allocation Fund | 60,298 | 0.04 | 2.47 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.36 | 11.74 |
| Diluted EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| Cash EPS (Rs.) | 13.21 | 13.98 | 11.23 | 13.91 | 16.17 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Dividend / Share (Rs.) | 3.00 | 3.00 | 2.50 | 2.50 | 2.50 |
| Revenue From Operations / Share (Rs.) | 112.08 | 117.08 | 111.80 | 106.60 | 94.97 |
| PBDIT / Share (Rs.) | 16.43 | 17.49 | 14.24 | 17.66 | 20.86 |
| PBIT / Share (Rs.) | 10.07 | 11.57 | 9.21 | 13.09 | 16.43 |
| PBT / Share (Rs.) | 9.24 | 10.82 | 8.44 | 12.48 | 15.75 |
| Net Profit / Share (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| PBDIT Margin (%) | 14.66 | 14.94 | 12.73 | 16.56 | 21.96 |
| PBIT Margin (%) | 8.98 | 9.88 | 8.23 | 12.28 | 17.30 |
| PBT Margin (%) | 8.24 | 9.24 | 7.54 | 11.70 | 16.58 |
| Net Profit Margin (%) | 6.10 | 6.87 | 5.55 | 8.76 | 12.35 |
| Return on Networth / Equity (%) | 8.11 | 10.01 | 8.32 | 13.21 | 18.54 |
| Return on Capital Employeed (%) | 10.83 | 13.12 | 11.32 | 16.96 | 23.64 |
| Return On Assets (%) | 6.16 | 7.38 | 6.19 | 9.76 | 13.40 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 1.02 | 1.12 | 1.14 | 1.16 | 1.17 |
| Current Ratio (X) | 2.74 | 2.40 | 2.54 | 2.57 | 2.40 |
| Quick Ratio (X) | 1.50 | 1.25 | 1.34 | 1.11 | 1.46 |
| Inventory Turnover Ratio (X) | 4.82 | 1.99 | 1.91 | 2.39 | 1.99 |
| Dividend Payout Ratio (NP) (%) | 43.84 | 31.04 | 40.28 | 26.69 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 22.71 | 17.88 | 22.25 | 17.93 | 0.00 |
| Earning Retention Ratio (%) | 56.16 | 68.96 | 59.72 | 73.31 | 0.00 |
| Cash Earning Retention Ratio (%) | 77.29 | 82.12 | 77.75 | 82.07 | 0.00 |
| Interest Coverage Ratio (X) | 19.79 | 23.30 | 18.42 | 28.67 | 30.34 |
| Interest Coverage Ratio (Post Tax) (X) | 9.24 | 11.73 | 9.03 | 16.18 | 18.07 |
| Enterprise Value (Cr.) | 10084.44 | 20231.08 | 21055.11 | 26520.33 | 21706.20 |
| EV / Net Operating Revenue (X) | 3.61 | 6.94 | 7.57 | 10.00 | 9.20 |
| EV / EBITDA (X) | 24.66 | 46.46 | 59.42 | 60.35 | 41.88 |
| MarketCap / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| Retention Ratios (%) | 56.15 | 68.95 | 59.71 | 73.30 | 0.00 |
| Price / BV (X) | 4.83 | 10.15 | 11.39 | 15.06 | 13.81 |
| Price / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Relaxo Footwears Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 13.98 (Mar 24) to 13.21, marking a decrease of 0.77.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.08. It has decreased from 117.08 (Mar 24) to 112.08, marking a decrease of 5.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.43. This value is within the healthy range. It has decreased from 17.49 (Mar 24) to 16.43, marking a decrease of 1.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10.07. This value is within the healthy range. It has decreased from 11.57 (Mar 24) to 10.07, marking a decrease of 1.50.
- For PBT / Share (Rs.), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.24, marking a decrease of 1.58.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For PBDIT Margin (%), as of Mar 25, the value is 14.66. This value is within the healthy range. It has decreased from 14.94 (Mar 24) to 14.66, marking a decrease of 0.28.
- For PBIT Margin (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 8.98, marking a decrease of 0.90.
- For PBT Margin (%), as of Mar 25, the value is 8.24. This value is below the healthy minimum of 10. It has decreased from 9.24 (Mar 24) to 8.24, marking a decrease of 1.00.
- For Net Profit Margin (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.10, marking a decrease of 0.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 10.01 (Mar 24) to 8.11, marking a decrease of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 10.83, marking a decrease of 2.29.
- For Return On Assets (%), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 6.16, marking a decrease of 1.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.12 (Mar 24) to 1.02, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.74, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.50, marking an increase of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.82. This value is within the healthy range. It has increased from 1.99 (Mar 24) to 4.82, marking an increase of 2.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 43.84. This value is within the healthy range. It has increased from 31.04 (Mar 24) to 43.84, marking an increase of 12.80.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.71. This value is within the healthy range. It has increased from 17.88 (Mar 24) to 22.71, marking an increase of 4.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 56.16. This value is within the healthy range. It has decreased from 68.96 (Mar 24) to 56.16, marking a decrease of 12.80.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.29. This value exceeds the healthy maximum of 70. It has decreased from 82.12 (Mar 24) to 77.29, marking a decrease of 4.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 19.79. This value is within the healthy range. It has decreased from 23.30 (Mar 24) to 19.79, marking a decrease of 3.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 9.24, marking a decrease of 2.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,084.44. It has decreased from 20,231.08 (Mar 24) to 10,084.44, marking a decrease of 10,146.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 6.94 (Mar 24) to 3.61, marking a decrease of 3.33.
- For EV / EBITDA (X), as of Mar 25, the value is 24.66. This value exceeds the healthy maximum of 15. It has decreased from 46.46 (Mar 24) to 24.66, marking a decrease of 21.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For Retention Ratios (%), as of Mar 25, the value is 56.15. This value is within the healthy range. It has decreased from 68.95 (Mar 24) to 56.15, marking a decrease of 12.80.
- For Price / BV (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 3. It has decreased from 10.15 (Mar 24) to 4.83, marking a decrease of 5.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Relaxo Footwears Ltd:
- Net Profit Margin: 6.1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.83% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.11% (Industry Average ROE: 8.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.24
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57.4 (Industry average Stock P/E: 46.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Footwears | Aggarwal City Square, Plot No. 10, Manglam Place, Delhi Delhi 110085 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Kumar Dua | Chairman & Managing Director |
| Mr. Mukand Lal Dua | Whole Time Director |
| Mr. Nikhil Dua | Whole Time Director |
| Mr. Gaurav Dua | Whole Time Director |
| Mr. Sushil Batra | Executive Director |
| Mr. Kuldip Singh Dhingra | Independent Director |
| Mr. Rajeev Rupendra Bhadauria | Independent Director |
| Ms. Richa Arora | Independent Director |
| Mr. Yogesh Kapur | Independent Director |
| Mr. Raj Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of Relaxo Footwears Ltd?
Relaxo Footwears Ltd's intrinsic value (as of 07 January 2026) is ₹325.64 which is 19.00% lower the current market price of ₹402.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹10,006 Cr. market cap, FY2025-2026 high/low of ₹628/375, reserves of ₹2,085 Cr, and liabilities of ₹2,870 Cr.
What is the Market Cap of Relaxo Footwears Ltd?
The Market Cap of Relaxo Footwears Ltd is 10,006 Cr..
What is the current Stock Price of Relaxo Footwears Ltd as on 07 January 2026?
The current stock price of Relaxo Footwears Ltd as on 07 January 2026 is ₹402.
What is the High / Low of Relaxo Footwears Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Relaxo Footwears Ltd stocks is ₹628/375.
What is the Stock P/E of Relaxo Footwears Ltd?
The Stock P/E of Relaxo Footwears Ltd is 57.4.
What is the Book Value of Relaxo Footwears Ltd?
The Book Value of Relaxo Footwears Ltd is 84.7.
What is the Dividend Yield of Relaxo Footwears Ltd?
The Dividend Yield of Relaxo Footwears Ltd is 0.75 %.
What is the ROCE of Relaxo Footwears Ltd?
The ROCE of Relaxo Footwears Ltd is 11.2 %.
What is the ROE of Relaxo Footwears Ltd?
The ROE of Relaxo Footwears Ltd is 8.31 %.
What is the Face Value of Relaxo Footwears Ltd?
The Face Value of Relaxo Footwears Ltd is 1.00.